StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
SCHOTT Pharma AG & Co. KGaA
Frankfurt Stock Exchange:1SXP.F
Sector
Location
Market Cap
USD 4.68 B
Share Price
USD 31.54
Avg Daily Volume
211
Change (1 day)
1.06%
Change (1 year)
-5.93%
Change (YTD)
20.48%
SCHOTT Pharma AG & Co. KGaA Gross Profit Margin for the year ending September 30, 2024: 33.71%
SCHOTT Pharma AG & Co. KGaA Gross Profit Margin is 33.71% for the year ending September 30, 2024, a -4.30% change year over year. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.
-
SCHOTT Pharma AG & Co. KGaA Gross Profit Margin for the year ending September 30, 2023 was 35.22%, a -2.44% change year over year.
-
SCHOTT Pharma AG & Co. KGaA Gross Profit Margin for the year ending September 30, 2022 was 36.10%, a 3.54% change year over year.
-
SCHOTT Pharma AG & Co. KGaA Gross Profit Margin for the year ending September 30, 2021 was 34.87%, a 3.92% change year over year.
-
SCHOTT Pharma AG & Co. KGaA Gross Profit Margin for the year ending September 30, 2020 was 33.55%.
Competitors
Chugai Pharmaceutical Co., Ltd.
USD 49.30
4519.T
+0.76
1.57%
West Pharmaceutical Services, Inc.
USD 222.26
WST
+1.04
0.47%
Yuhan Corporation
USD 77.85
000100.KS
-2.67
-3.31%
Zhejiang Huahai Pharmaceutical Co., Ltd.
USD 3.21
600521.SS
+0.14
4.63%
Gan & Lee Pharmaceuticals.
USD 7.84
603087.SS
-0.05
-0.69%
Cohance Lifesciences Limited
USD 12.12
COHANCE.NS
+0.33
2.83%
Tonghua Dongbao Pharmaceutical Co., Ltd.
USD 1.13
600867.SS
-0.00
-0.21%
Anhui Anke Biotechnology (Group) Co., Ltd.
USD 1.24
300009.SZ
-0.01
-0.53%
Neuland Laboratories Limited
USD 140.35
NEULANDLAB.NS
+3.79
2.77%
Anbio Biotechnology Class A Ordinary Shares
USD 36.99
NNNN
+0.79
2.18%
Qingdao Baheal Medical INC.
USD 2.94
301015.SZ
-0.06
-1.87%
Eli Lilly and Company
USD 780.67
LLY
+1.39
0.18%
AbbVie Inc.
USD 189.28
ABBV
-1.47
-0.77%
Roche Holding AG
USD 347.79
RO.SW
+3.30
0.96%
AstraZeneca PLC
USD 140.96
AZN.L
+1.64
1.18%
Merck & Co., Inc.
USD 80.93
MRK
-1.46
-1.77%
Amgen Inc.
USD 298.24
AMGN
+1.39
0.47%
Pfizer Inc.
USD 25.38
PFE
+0.06
0.24%
Gilead Sciences, Inc.
USD 111.75
GILD
+0.24
0.21%
Sanofi
USD 98.03
SAN.PA
+1.08
1.11%
Key Data
| Date | Gross Profit Margin | EBIT Margin | EBITDA Margin | Net Income Margin |
|---|
Competitors
Chugai Pharmaceutical Co., Ltd.
USD 49.30
4519.T
+0.76
1.57%
West Pharmaceutical Services, Inc.
USD 222.26
WST
+1.04
0.47%
Yuhan Corporation
USD 77.85
000100.KS
-2.67
-3.31%
Zhejiang Huahai Pharmaceutical Co., Ltd.
USD 3.21
600521.SS
+0.14
4.63%
Gan & Lee Pharmaceuticals.
USD 7.84
603087.SS
-0.05
-0.69%
Cohance Lifesciences Limited
USD 12.12
COHANCE.NS
+0.33
2.83%
Tonghua Dongbao Pharmaceutical Co., Ltd.
USD 1.13
600867.SS
-0.00
-0.21%
Anhui Anke Biotechnology (Group) Co., Ltd.
USD 1.24
300009.SZ
-0.01
-0.53%
Neuland Laboratories Limited
USD 140.35
NEULANDLAB.NS
+3.79
2.77%
Anbio Biotechnology Class A Ordinary Shares
USD 36.99
NNNN
+0.79
2.18%
Qingdao Baheal Medical INC.
USD 2.94
301015.SZ
-0.06
-1.87%
Eli Lilly and Company
USD 780.67
LLY
+1.39
0.18%
AbbVie Inc.
USD 189.28
ABBV
-1.47
-0.77%
Roche Holding AG
USD 347.79
RO.SW
+3.30
0.96%
AstraZeneca PLC
USD 140.96
AZN.L
+1.64
1.18%
Merck & Co., Inc.
USD 80.93
MRK
-1.46
-1.77%
Amgen Inc.
USD 298.24
AMGN
+1.39
0.47%
Pfizer Inc.
USD 25.38
PFE
+0.06
0.24%
Gilead Sciences, Inc.
USD 111.75
GILD
+0.24
0.21%
Sanofi
USD 98.03
SAN.PA
+1.08
1.11%